Supporting throughout the entire continuum of care
Baxter is firmly committed to supporting end-stage kidney disease patients and their healthcare providers throughout the entire continuum of care. Our clinically effective solutions help ensure smooth transitions for patients as they sequence through different treatment steps. Thereby, we enable you to deliver the right therapy throughout the entire patient journey.
Peritoneal Dialysis - combined with Remote Patient Management – offers the potential to improve renal patients’ clinical outcomes and increase lifestyle flexibility.
Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.
HDx - also known as expanded Hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.
Important Safety Information
For safe and proper use of products mentioned herein, please refer to the appropriate Operators Manual or Instructions for Use.